PROK
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 39 | +7 | 26.59M | $54.23M | +13 | −6 |
| Q1 2026 | 33 | -2 | 21.95M | $39.29M | +2 | −4 |
| Q4 2025 | 35 | +1 | 22.33M | $50.02M | +1 | n/a |
| Q3 2025 | 13 | +1 | 13.95M | $33.76M | +2 | −1 |
| Q2 2025 | 9 | +1 | 5.91M | $3.50M | +2 | −1 |
| Q1 2025 | 5 | -1 | 4.30M | $3.77M | n/a | −1 |
| Q4 2024 | 6 | 0 | 4.14M | $7.00M | +1 | −1 |
| Q3 2024 | 5 | 0 | 2.34M | $4.50M | +2 | −2 |
| Q2 2024 | 5 | n/a | 1.27M | $3.13M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.09M | n/a | $2.68M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Millennium Management ✦ | 91.87K | n/a | $226,008 | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Marshall Wace ✦ | 50.24K | n/a | $123,595 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 20.52K | n/a | $50,474 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 5 | T. Rowe Price ✦ | 19.19K | n/a | $48,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 68 holders, 42.65M shares, $75.77M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 222.95K sh · $316,564
Director · 27.05K sh · $38,411
Director · 222.95K sh · $321,203
Director · 27.05K sh · $38,972
Director · 229.34K sh · $314,468
Director · 27.83K sh · $38,155
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology